Team:Bielefeld-CeBiTec/Partners
Expanding the Genetic Code
Human Practice ▼
Additional ▼
Results ▼
Theory ▼
Bielefeld-CeBiTec 2017
Collaborations
Team ▼
Partners
Notebook ▼
Aim of the Project
Unnatural Base Pair ▼
Translational System ▼
Toolbox ▼
Overview
Unnatural Base Pairs
Uptake and Biosynthesis
Retention System
Challenges
Overview
Translation Mechanism
Library and Selection
Overview
Analyzing
Photoswitching
Labeling
Photolysis
Fusing
Results Overview
Unnatural Base Pair ▼
Translational System ▼
Toolbox ▼
Parts ▼
Achievements
Overview
Uptake
Biosynthesis
Retention System
Development of New Methods
Overview
Translation Mechanism
Library and Selection
Overview
Analyzing
Photoswitching
Labeling
Photolysis
Fusing
Parts
Basic Parts
Composite Parts
Part Collection
Improve
Hardware
Software
Modeling
Measurement
Applied Design
InterLab Study
Overview
Gold
Silver
Public Engagement
Members
Advisors
Bielefeld
CeBiTec
Bielefeld University
Attributions
Methods
Oligonucleotides
Labjournal
Labnotes Generator
Safety
Sponsors and Supporters
Gold Sponsors
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of €15.0 billion in 66 countries.Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
The STOCKMEIER Group is known throughout Europe as a reliable supplier of chemical products. By upholding this aspiration, it has grown from a regional trading company to an international group with over 1,300 employees. Today the STOCKMEIER Group is made up of companies that provide distribution, manufacturing and various services related to chemicals – in 44 locations around the world. Today, Peter Stockmeier leads the family business in the third generation. Sustainable and long-term relationships to customers and suppliers are a main building block of success. As well as the engagement of the employees. The STOCKMEIER Group offers apprentices jobs in various departments for decades. Furthermore STOCKMEIER supports scientific projects of young talents, e.g. in the framework of iGEM.
Biolegio B.V. was founded in 1996 on the campus of the Radboud University in Nijmegen, the Netherlands. After 20 years the company is still leaded by the founder Ruud van der Steen extended by a team of chemists, biologists, engineers, technicians and administration staff working hand in hand in a familial structure. The product range has broadened from custom made primers to very long and highly modified oligonucleotides, fitted with every commercially available modification. Making them suitable for a wide range of applications including (Next Generation) Sequencing, PCR, Real-Time PCR, SNP detection, genotyping, gene expression, cloning, CRISPR and mutation detection. By following our own defined core values: Boundless innovation, approachable flexibility, structured efficiency, proven experience and trustable convenience we build the backbone to reach our main aim - a successful and trustful partnership with our customers all over the world.
Silver Sponsors
Bronze Sponsors
Supporters
